Non Nucleoside Reverse Transcriptase Inhibitors (nnrtis) - Catalysis

Relevant Publications

HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals.

Issue Release: 2024

Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.

Issue Release: 2024

Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.

Issue Release: 2024

Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.

Issue Release: 2024

Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing.

Issue Release: 2024

HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021.

Issue Release: 2024

Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia.

Issue Release: 2024

High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana.

Issue Release: 2024

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.

Issue Release: 2024

Selected Milestones in Antiviral Drug Development.

Issue Release: 2024

Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China.

Issue Release: 2024

Design and optimization of piperidine-substituted thiophene[3,2-]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles.

Issue Release: 2024

HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola.

Issue Release: 2024

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

Issue Release: 2024

Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.

Issue Release: 2024

Tri-substituted 1,3,5-triazine-based analogs as effective HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs): A systematic review.

Issue Release: 2024

Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.

Issue Release: 2024

Comparative on the Efficacy and Safety of ANV-Based Versus EFV-Based ART in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China.

Issue Release: 2024

Molecular genetic characterization analysis of a novel HIV-1 circulating recombinant form (CRF156_0755) in Guangdong, China.

Issue Release: 2024

Molecular network characteristics and drug resistance analysis of 392 newly reported MSM HIV/AIDS cases in Chongqing, China.

Issue Release: 2024

How Do Catalysts Reduce Environmental Impact?

How Do Industrial Applications Ensure Reliability?

Why are Chemical Reagents Important in Catalysis?

What are the Advantages of Using In Situ Techniques?

What is Catalyst Coating?

How to Get Started with Publons?

What are Platinum Group Metals (PGMs)?

How Do Antimicrobial Coatings Work?

What is the catalytic mechanism of LCAT?

What are Defects in Catalysis?

Partnered Content Networks

Relevant Topics